Series: Increasing the Scope of your Analytical Toolbox with UltraPerformance Convergence Chromatography (UPC2) - Episode 2
Series: Increasing the Scope of your Analytical Toolbox with UltraPerformance Convergence Chromatography (UPC2) - Episode 2
Wednesday, November 28, 2012
9:00 AM EST; 15:00 (GMT + 1)
Series: Increasing the Scope of Your Analytical Toolbox with UltraPerformance Convergence Chromatography UPC²
Episode 2 : Solving Complex Challenges in the Pharmaceutical Laboratory with the ACQUITY UPC² System
Do you know what your next sample will be? Could it be hydrophobic, hydrophilic, volatile, nonvolatile or chiral? Are you being challenged to reduce toxic solvent waste and go green? Which technique will you choose from your analytical toolbox to get the best possible separation? In this webcast series, we will be discussing how analytical laboratories can benefit from UltraPerformance Convergence Chromatography UPC² a new category of separation science that provides an exponential increase in performance and selectivity to the chromatographic laboratory. Through a variety of topics and scientific examples, this series will help you to gain a better understanding of UPC² technology, how to realize its benefits and how to easily adopt it into your laboratory. Attendees of today's webcast will learn about how the expanded selectivity capability of The ACQYUITY UPC² system will help solve complex challenges in the pharmaceutical laboratory.
Learn how UPC² technology can be implemented in your discovery and development laboratories. As pharmaceutical and life sciences companies look to understand more complex science, new technologies need to be utilized to help drive new discoveries. This seminar will cover profiling of complex metabolomic samples, routine screening for compound libraries, reaction monitoring for synthetic chemistry groups, and the development and validation of routine analysis for basic pharmaceuticals. Additionally, we will cover how The ACQYUITY UPC² System complements reversed phase liquid chromatography (RPLC).
Sponsored by: Waters Corporation
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
